Single Strand Conformation Polymorphism (SSCP) as a quick and reliable method to genotype M235T polymorphism of angiotensinogen gene

被引:12
作者
Bettinaglio, P [1 ]
Galbusera, A [1 ]
Caprioli, J [1 ]
Orisio, S [1 ]
Perna, A [1 ]
Arnoldi, F [1 ]
Bucchioni, S [1 ]
Noris, M [1 ]
机构
[1] Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Villa Camozzi Ranica, Italy
关键词
Single Strand Conformation Polymorphism (SSCP); angiotensinogen; M235T polymorphism; Y248C polymorphism; angiotensin-converting enzyme; ACE I/D polymorphism; renin angiotensin system; diabetic nephropathy;
D O I
10.1016/S0009-9120(02)00308-9
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Conflicting results on the relationship between M235T polymorphism of angiotensinogen (AGT) gene and diabetic nephropathy are reported in the literature, probably due to the small number of subjects, to different inclusion criteria and the different genotype analysis methods used. The aim of the present study was to set up a fast, cheap and reliable method to allow the genotyping of M235T polymorphism in a large number of subjects. Design and methods: We developed in our laboratory a new specifically designed PCR-SSCP method for M235T genotyping whose specificity was compared with that of Allele Specific PCR (ASPCR) and Mutagenically Separated PCR (MS-PCR). The exact M235T genotype was estabilished by direct sequencing. The new PCR-SSCP method was then used to genotype a population of 1171 hypertensive, normoalbuminuric type 11 diabetes mellitus patients. The patients were also genotyped for ACE I/D polymorphism. For comparison a group of hypertensive non diabetic patients (n = 88) were also screened. Results: The PCR-SSCP method identified the M235T polymorphism with no misinterpretation at variance with ASPCR and MS-PCR methods that showed a preferential amplification of the T allele. The rare Y248C polymorphism of the AGT gene was also detected by PCR-SSCP. In diabetic hypertensive patients the prevalence of TT genotype was higher than in normotensive healthy controls and equivalent to that found in hypertensive non diabetic patients. Conclusions: The PCR-SSCP method for detection of M235T polymorphism is a powerful and sensitive tool for rapid, cheap and efficient screening of a large number of samples. The results obtained with this method demonstrate an association of the TT genotype of AGT gene with hypertension, both in diabetic and non diabetic patients. (C) 2002 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:363 / 368
页数:6
相关论文
共 21 条
[1]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[2]   Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes [J].
Doria, A ;
Onuma, T ;
Gearin, G ;
Freire, MBS ;
Warram, JH ;
Krolewski, AS .
HYPERTENSION, 1996, 27 (05) :1134-1139
[3]   A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM [J].
Fogarty, DG ;
Harron, JC ;
Hughes, AE ;
Nevin, NC ;
Doherty, CC ;
Maxwell, AP .
DIABETES, 1996, 45 (09) :1204-1208
[4]   A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro [J].
Inoue, I ;
Nakajima, T ;
Williams, CS ;
Quackenbush, J ;
Puryear, R ;
Powers, M ;
Cheng, T ;
Ludwig, EH ;
Sharma, AM ;
Hata, A ;
Jeunemaitre, X ;
Lalouel, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1786-1797
[5]   Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy [J].
Jeffers, BW ;
Estacio, RO ;
Raynolds, MV ;
Schrier, RW .
KIDNEY INTERNATIONAL, 1997, 52 (02) :473-477
[6]   MOLECULAR-BASIS OF HUMAN HYPERTENSION - ROLE OF ANGIOTENSINOGEN [J].
JEUNEMAITRE, X ;
SOUBRIER, F ;
KOTELEVTSEV, YV ;
LIFTON, RP ;
WILLIAMS, CS ;
CHARRU, A ;
HUNT, SC ;
HOPKINS, PN ;
WILLIAMS, RR ;
LALOUEL, JM ;
CORVOL, P .
CELL, 1992, 71 (01) :169-180
[7]  
Malin R, 2000, CLIN CHEM, V46, P880
[8]   RELATIONSHIPS BETWEEN ANGIOTENSIN-I CONVERTING-ENZYME GENE POLYMORPHISM, PLASMA-LEVELS, AND DIABETIC RETINAL AND RENAL COMPLICATIONS [J].
MARRE, M ;
BERNADET, P ;
GALLOIS, Y ;
SAVAGNER, F ;
GUYENE, TT ;
HALLAB, M ;
CAMBIEN, F ;
PASSA, P ;
ALHENCGELAS, F .
DIABETES, 1994, 43 (03) :384-388
[9]   Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes [J].
Marre, M ;
Jeunemaitre, X ;
Gallois, Y ;
Rodier, M ;
Chatellier, G ;
Sert, C ;
Dusselier, L ;
Kahal, Z ;
Chaillous, L ;
Halimi, S ;
Muller, A ;
Sackmann, H ;
Bauduceau, B ;
Bled, F ;
Passa, P ;
AlhencGelas, F .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1585-1595
[10]   ANGIOTENSIN-CONVERTING ENZYME POLYMORPHISM AND DEVELOPMENT OF DIABETIC NEPHROPATHY IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
MIZUIRI, S ;
HEMMI, H ;
INOUE, A ;
YOSHIKAWA, H ;
TANEGASHIMA, M ;
FUSHIMI, T ;
ISHIGAMI, M ;
AMAGASAKI, Y ;
OHARA, T ;
SHIMATAKE, H ;
HASEGAWA, A .
NEPHRON, 1995, 70 (04) :455-459